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Respiratory syncytial virus (RSV) induces the production of a number of cytokines and chemokines by activation of nuclear factor kappa
B (NF-nB). The activation of NF-nB has been shown to depend on viral replication in the infected cells. In this study, we demonstrate that
expression of RSV M2-1 protein, a transcriptional processivity and anti-termination factor, is sufficient to activate NF-nB in A549 cells.
Electromobility shift assays show increased NF-nB complexes in the nuclei of M2-1-expressing cells. M2-1 protein is found in nuclei of M2-
1-expressing cells and in RSV-infected cells. Co-immunoprecipitations of nuclear extracts of M2-1-expressing cells and of RSV-infected cells
revealed an association of M2-1 with Rel A protein. Furthermore, the activation of NF-nB depends on the C-terminus of the RSV M2-1
protein, as shown by NF-nB-induced gene expression of a reporter gene construct.
D 2004 Elsevier Inc. All rights reserved.
Keywords: Respiratory syncytial virus (RSV); M2-1 protein; Nuclear factor nB; NF-nBIntroduction
Human respiratory syncytial virus (RSV) is one of the
most important etiologic agents of pediatric respiratory
disease worldwide (reviewed in Collins et al., 2001),
accounting for over 100,000 hospitalizations in the United
States yearly (Shay et al., 1999). Analyses of nasal wash and
tracheal aspirates from RSV-infected individuals have
confirmed the presence of elevated levels of inflammatory
cytokines and chemokines (Collins et al., 2001). Histopa-
thological studies of fatal RSV-induced respiratory disease
have identified necroses of small airway epithelia, as well as
peri-bronchial mononuclear cell infiltration and plugging of
the bronchial lumen by sloughed epithelium and mucus
(Aherne et al., 1970). These findings suggest that, in
addition to the direct viral cytopathology, the inflammatory
response triggered by the infection of respiratory epithelial
cells is an essential pathogenic component of RSV disease.0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.10.031
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E-mail address: reimers.kerstin@mh-hannover.de (K. Reimers).NF-kappa B (NF-nB) is one of the pivotal regulators of
pro-inflammatory gene expression, and as such, induces the
transcription of pro-inflammatory cytokines, chemokines,
adhesion molecules, matrix metalloproteinases, cyclooxyge-
nase 2, and inducible nitric oxide synthase (reviewed in Li
and Verma, 2002). The mammalian NF-nB family consists
of Rel A (p65), NF-nB1 (p50; p105), NF-nB2 (p50; p100),
c-Rel and Rel B. All of these proteins have a structurally
conserved, 300 amino acid amino-terminal region, known as
the Rel homology domain, which contains the dimerization,
nuclear-location and DNA-binding domains. The Rel A, Rel
B, and c-Rel proteins also have a carboxy-terminal non-
homologous transactivation domain, which strongly acti-
vates transcription from NF-nB binding sites in target genes.
NF-nB is composed of homo- or heterodimers of Rel family
members.
A common feature of the regulation of the Rel family
transcription factors is their sequestration in the cytoplasm
as inactive complexes by a class of inhibitory molecules
known as InBs. The most common of these are the InBa,
InBh, and InBE (Ghosh et al., 1998). Treatment of cells with05) 260–268
Fig. 1. M2-1 induced NF-nB DNA binding in transfected A549 cells. Cells
were transfected with expression plasmids encoding for RSV gene
products. Forty-eight h post-transfection nuclear extracts were prepared
and incubated with 32P-labeled NF-nB consensus probe and analyzed by
EMSA. (A) Lane 1: empty vector, lane 2: pTriEx-N, lane 3: pTriEx-P, lane
4: pTriEx-M2-1, lane 5: pTriEx-M, lane 6: pTriEx-M2-2, lane 7: pTriEx-
NS1, lane 8: pTriEx-NS2. (B) Completion assay. Nuclear extracts of M2-1
transfected A549 cells were incubated with 32P-labeled NF-nB consensus
probe and analyzed by EMSA and an additionally 20-fold access of cold-
labeled oligonucleotides as indicated. Lane 1: untreated sample, lane 2:
NF-nB consensus probe, lane 3: SP-1 consensus probe. C Transfected A549
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cytoplasmic complexes and in the translocation of free NF-
nB to the nucleus. The dissociation of the cytoplasmic
complexes is thought to be triggered by the phosphorylation
and subsequent degradation of the InB proteins. InBa
regulates transient NF-nB activation, whereas InBg main-
tains persistent NF-nB activation (May and Gosh, 1997).
Previous studies have demonstrated that RSV infection of
airway epithelial cells results in persistent NF-nB activation
(Bitko et al., 1997; Garofalo et al., 1996). Furthermore, the
persistent activation of NF-nB was shown to be dependent
on RSV replication (Fiedler et al., 1996). The aim of our
study was to identify the RSV protein(s) which might be
responsible for the NF-nB activation.
RSV is a nonsegmented, single-stranded RNA virus with
a genome of 10 genes, encoding at least 11 proteins (Collins
et al., 1984). RSV replicates in the cytoplasm of respiratory
epithelial cells. The A549 cell line, derived from an alveolar
cell carcinoma of the lung, retains features of type II
alveolar epithelial cells and is susceptible to RSV infection
(Patel et al., 1995). We used transfected A549 cells as a
model for studying RSV-induced nuclear translocation of
NF-nB.
The M2-1 protein of RSV is a transcriptional processivity
and an anti-termination factor (Collins et al., 2001). Here,
we show that the M2-1 protein is able and sufficient to
induce Rel A (p65) translocation to the nucleus. Nuclear
extracts of M2-1-transfected cells reveal an association
between M2-1 and Rel A protein.cells were lysed and analyzed by Western Blotting for foreign gene
expression. Immunodetection was carried out with anti-RSV polyclonal
antibodies. Lane 1: M2-1, Lane 2: P, lane 3: N.Results
M2-1 protein induces NF-jB activation
As mentioned earlier, in uninduced cells, NF-nB has
been shown to be bound to its inhibitor InB and be present
as an inactive complex in the cytoplasm. Signals which
activate NF-nB also phosphorylate InB, thereby targeting
InB for proteolysis and degradation, resulting in the release
of NF-nB from the complex. Released NF-nB translocates
into the nucleus, activating transcription of genes that
contain NF-nB sites.
To investigate which of the RSV gene products mediate
activation of NF-nB, we undertook two related approaches.
First, 48-h post-transfection nuclear extracts were prepared
from A549 cells which had been transfected with RSV
cDNA constructs. They were then tested for the presence
of proteins that could bind a consensus synthetic NF-nB
oligonucleotide in electrophoretic mobility shift assays
(EMSA). As shown in Fig. 1, lane 4, the extract of cells
transfected with pTriEx-M2-1 (henceforth referred to as
M2-1cDNA) generated a DNA–protein complex of
retarded mobility, while those transfected with N, P, M,
M2-2, NS1, and NS2cDNA failed to produce complexes
(Fig. 1A, lanes 2, 3, 5, 6, 7, and 8). The formation of thecomplex by the extract of M2-1cDNA-transfected cells was
prevented by a 20-fold molar excess of the unlabeled
oligonucleotide, demonstrating specificity of complex
formation (Fig. 1B). Fig. 1C shows that the expression
levels of M2-1, P, and N are almost similar in the
transfected cells.
Next, we attempted to determine whether M2-1 protein
activates NF-nB to the same extent as RSV infection.
Therefore, A549 cells were infected with RSV, transfected
with M2-1cDNA or left untreated. After 48 h, nuclear
extracts were prepared and placed into wells pre-coated with
immobilized oligonucleotide containing the NF-nB con-
sensus site. The amount of bound Rel A, the activation
subunit of NF-nB, was subsequently determined colometri-
cally. Fig. 2A shows that M2-1 protein generated by
recombinant expression induces activation of Rel A to a
similar extent as RSV infection.
M2-1 co-localizes with Rel A in nuclei of
M2-1cDNA-transfected cells
In immunofluorescence studies, co-localization of M2-1
and Rel A in M2-1cDNA-transfected A549 cells was
Fig. 2. ELISA detection of nuclear NF-nB RelA in A549 cells. Cells were infected with RSV long, transfected with pTriEx-M2-1 or left untreated. (A) After 48
h, nuclear proteins were prepared as described in Materials and methods. 20 Al nuclear extract containing 5 Ag total protein were placed into a 96-well plate
coated with immobilized oligonucleotide containing the NF-nB consensus site (5V-GGGACTTTCC-3V) and incubated for 1 h at room temperature. After
washing, anti-RelA was added and incubated for 1 h at room temperature. Anti-RelA was detected using HRP-conjugated secondary antibody. The amount of
NF-nB RelAwas determined colorimetrically 10 min later after adding stopping solution at 450 nm wavelength. All experiments were carried out in triplicates
and presented with standard deviation. Bar 1: nuclear extract of RSV-infected cells, bar 2: nuclear extracts of M2-1 transfected cells, bar 3: nuclear extracts of
control cells. (B) Determination of transfection efficiency and infection ratio. In the upper panel, RSV-infected cells are shown. In the lower panel, cells were
transfected with pTriEx-M2-1. M2-1 protein was detected using a mouse monoclonal antibody (11F4) directed against M2-1 with goat anti-mouse IgG/Alexa
Fluor 594 secondary antibody. (C) Cells were lysed as described in Materials and methods and subjected to SDS-PAGE analysis followed by immunodetection
of M2-1 protein with mouse monoclonal antibody 11F4. Lane 1: RSV-infected cells, lane 2: pTriEx-M2-1 transfected cells.
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immunofluorescence test. In Fig. 3A, M2-1 (red fluores-
cence) is detected in the cytoplasm and nucleus of one
transfected cell, whereas nontransfected cells show no
signal. In Fig. 3B, Rel A can be seen in the cytoplasm
and nucleus of the same transfected cell (green fluores-
cence), whereas nontransfected cells possess only cytoplas-
mic fluorescence.
Detection of M2-1 in nuclei of M2-1cDNA-transfected and
in RSV-infected A549 cells
The presence of M2-1 in nuclei of M2-1cDNA-trans-
fected cells was unexpected. RSV replicates in the
cytoplasm without nuclear involvement, and the virus can
grow in enucleated cells (Collins et al., 2001). M2-1 is
concentrated in cytoplasmic inclusions of infected cells as
described (Garcia et al., 1993). To verify the intra-nuclear
presence of M2-1, nuclei of RSV-infected A549 cells aswell as those transfected with M2-1cDNA were prepared.
The samples were then subjected to immunoblot analysis.
M2-1 could be detected 24 h post-transfection (Fig. 4B) and
24 h after RSV infection (Fig. 4D).
M2-1 interacts with Rel A
The next step was to determine whether there is a direct
interaction between M2-1 and Rel A protein. We carried
out immunoprecipitations with monoclonal anti-M2-1 anti-
body on nuclear extracts of A549 cells either transfected
with M2-1cDNA or infected with RSV. The immunopre-
cipitates were run on SDS-PAGE, followed by Western
blotting. The blots were stained with anti-Rel A antibody
(Fig. 5A) or with anti M2-1 antibody (Fig. 5B). As can be
seen in Fig. 5A, Rel A could be co-precipitated from M2-
1cDNA-transfected cells (lane 1) as well as RSV-infected
cells (lane 3) using M2-1 antibody. Precipitates from mock-
infected cells did not contain Rel A (lane 2). In Fig. 3B,
Fig. 3. Indirect immunofluorescence of pTri-Ex-M2-1 transfected A549
cells. Cells were stained 48 h after transfection. Immunofluorescence was
detected using a mouse monoclonal antibody (11F4) directed against M2-1
with goat anti-mouse IgG/Alexa Fluor 594 secondary antibody and rabbit
polyclonal antibody against NF-nB RelA with a goat anti-rabbit IgG/Alexa
Fluor 488 secondary antibody. (A) Detection of M2-1 protein (red
fluorescence). The transfected cell shows a bright signal, whereas
nontransfected cells show no signal. (B) Detection of NF-nB RelA (green
fluorescence). Fluorescence can be observed in the cytoplasm of non-
activated cells and in the cytoplasm and in the nucleus of the activated cell.
(C) Merged image of the pictures A and B. (D–E) Empty vector transfected
cells. (D) Phase-contrast microscopy. (E) NF-nB RelA (green fluorescence)
was only detected in the cytoplasm of the transfected cells.
Fig. 4. Immunoblot analysis of M2-1 protein in pTriEx-M2-1-transfected
cells and RSV-infected A549 cells. (A) Five hundred forty-nine cells were
transfected with pTriEx-M2-1 (A–D) or infected with RSV (E–H). After the
indicated times, the cells were fractionated into cytoplasm and nuclei as
described in Materials and methods. The samples were subjected to
immunoblot analysis with a mouse monoclonal antibody (11F4) directed
against M2-1 (A, B, E, F) and goat polyclonal antibody against actin (C, D,
G, H). (A) Nuclei of pTriEx-M2-1 transfected A549 cells. M2-1 can be
detected 24 h post-transfection. (B) Cytoplasm of pTriEx-M2-1 transfected
A549 cells. M2-1 can be detected 12 h post-transfection. (C) Cytoplasm of
pTriEx-M2-1 transfected A549 cells incubated with anti-actin. All samples
show a comparable signal. (D) Nuclei of pTriEx-M2-1 transfected A549
cells incubated with anti-actin. Actin could not be detected in the nuclear
fractions. (E) Nuclei of RSV-infected A549 cells. M2-1 can be detected
24 h post-transfection. (F) Cytoplasm of RSV-infected A549 cells. M2-1
can be detected 12 h post-transfection. (G) Cytoplasm of RSV-infected
A549 cells incubated with anti-actin. All samples show a comparable
signal. (H) Nuclei of RSV-infected A549 cells incubated with anti-actin.
Actin could not be detected in the nuclear fractions.
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cells (lane 1) and in RSV-infected cells (lane 3). Precip-
itates from mock-infected cells contained no M2-1 (lane 2).To exclude that M2-1 and RelA interact by unspecific
binding to nucleic acids the samples were treated with
nucleases (Fig. 5C).
Fig. 5. Co-immunoprecipitation of Rel A with anti M2-1 antibody. Forty-eight hours after RSV infection or transfection with pTriEx-M2-1 of A549 cells,
nuclear extracts were prepared and mixed with monoclonal antibody (11F4) directed against M2-1 protein. Mock-infected cells were used as controls.
Immunoprecipitates were bound to Protein G Dynabeads. The eluted protein complexes were separated on SDS-PAGE and visualized with anti Rel A or anti
M2-1 antibody. Panel A, B, lane 1: immunoprecipitates from A549 cells transfected with pTriEx-M2-1. Panel A, B, lane 2: immunoprecipitates from mock-
infected cells. Panel A, B, lane 3: immunoprecipitates from RSV-infected cells. Panel A: samples in lanes 1–3 were treated with anti Rel A. Panel B: samples in
lanes 1–3 were treated with anti M2-1. Panel C: immunoprecipitates were treated with nucleases followed by SDS-PAGE and immunodetection with anti Rel
A. Lanes 1–3: immunoprecipitates from A549 cells from RSV-infected cells. Lanes 4–6: immunoprecipitates transfected with pTriEx-M2-1. Lane 7–9:
immunoprecipitates from mock-infected cells. Lanes 1, 4, and 7 are left untreated, lanes 2, 5, and 8 are treated with RNAse H, lanes 3, 6, and 9 are treated with
DNAse.
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We next studied the influence of M2-1 deletion mutants
on the activation of NF-nB. The deletion mutants were
generated using existing sites of restriction enzymes.Fig. 6. NF-nB activation after expression of M2-1 deletion mutants. (A)
Cloning scheme of M2-1 deletion mutants. Deletion mutants were
generated using existing restriction sites and subcloned into the expression
vector pTriEx. (B) NF-nB activity induced by expression of M2-1 and its
subfragments. A549 cells were co-transfected with pNF-B-LUC and
expression plasmids as indicated. Lane 1: pTriEx-M2-1, lane 2: pTriEx-
M2-2, lane 3: pTriEx-M, lane 4: pTriEx-Frag N1, lane 5: pTriEx-Frag N2,
lane 6: pTriEx-Frag C1, lane 7: pTriEx-Frag C2, lane 8: empty vector
control. Luciferase assay was performed 48 h post-transfection. All
transfections were carried out in triplicates and presented with standard
deviation, lane 9: RSV-infected cells.Several mutants with 3V- or 5V-deletions were cloned into
the expression vector pTriEx as shown in Fig. 6A. To follow
the activation process we used the reporter gene construct
pNF-nB-LUC, in which the expression of luciferase is
controlled by enhancer elements containing NF-nB-binding
sequences. A549 cells were co-transfected with p NF-nB-
LUC and expression plasmids. Luciferase assay was
performed 48 h post-transfection. Fig. 6B shows that only
the C-terminal fragments C1 and C2 possess NF-nB
activating capacity (lanes 6 and 7), whereas the N-terminal
fragments N1 and N2 of M2-1 fail to activate NF-nB. In
Fig. 7, two A549 cells transfected with either fragment C1
(picture A) or with fragment N1 (picture B) can be seen. RelFig. 7. Indirect immunofluorescence of transfected A549 cells. Forty-eight
hours post-transfection cells were fixed and incubated with goat polyclonal
antibody against RSV followed by donkey anti-goat IgG/Alexa Fluor 488
secondary antibody. Cells were examined with a fluorescence microscope.
(A) A549 cell transfected with pTriEx-Frag C1. A bright nuclear staining is
visible in a transfected cell. (B) A549 cell transfected with pTriEx-Frag N1.
Fluorescence is restricted to the cytoplasm of the transfected cell. (C)
Expression analysis of transfected cells. Cells were lysed, analyzed by
SDS-PAGE followed by immunodetection with anti RSV polyclonal
antibodies. Lane 1: pTriEx-M2-1-transfected cells, lane 2: pTriEx-Frag
N1-transfected cells, lane 3: pTriEx-Frag N2-transfected cells, lane 4:
pTriEx-Frag C1-transfected cells, lane 5: pTriEx-Frag C2-transfected cells.
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fragment C1 was able to translocate Rel A to the nucleus
(picture A), whereas fragment N1 had no such activity. Rel
A appears restricted to the cytoplasm of the nonactivated
cell.Discussion
NF-nB plays a key role in inflammatory disease (Tak and
Firestein, 2001). Thus, understanding the role of NF-nB
activation in the response to RSV infection is important for
understanding the inflammatory response as a whole. In
A549 cells, the kinetics of Rel A activation after RSV
infection occur slowly, requiring 6–12 h before significantly
detectable NF-nB protein accumulates in the nucleus
(Garofalo et al., 1996). This is in contrast to the extremely
rapid NF-nB activation in response to interleukin 1 and
tumor necrosis factor alpha (TNF-a), in which it is activated
within minutes (Osborn et al., 1989). In a Balb/c mouse
model, RSV infection led to distinct but sequentially
integrated, inducible NF-nB responses in the lung. The first
response occurred early after RSV inoculation and was
dependent on alveolar macrophages and Toll-like receptor 4
(TLR4) but independent of viral replication, whereas the
second response involved epithelial and/or inflammatory
cells and was TLR4 independent but required viral
replication (Haeberle et al., 2002). A role for RSV gene
expression in the activation of NF-nB had already been
suggested by its reversal with ribavirin, an inhibitor of RSV
replication (Fiedler et al., 1996). Our results confirm and
extend such studies, thereby providing direct evidence that
one single RSV gene product, the M2-1 protein, is sufficient
to activate NF-nB. Our conclusion is based on the following
facts:
(i) The expression of M2-1 protein in A549 cells
facilitated the translocation of NF-nB into the nucleus
of the transfected cells, as shown by electromobility
shift assay (Fig. 1). Expression of other RSV proteins,
however, did not induce NF-nB translocation signifi-
cantly. Bitko and Barik (1998) showed that RSV
infection led to the activation of NF-nB by a biphasic
mechanism: a transient or early activation involving
phosphorylation of the inhibitor InB polypeptides, and
a persistent or long-term activation requiring protein
kinase C and the generation of hypophosphorylated
InBh. At least a part of the activation was through a
novel mechanism in which the viral phosphoprotein P
associated with but was not dephosphorylated by
protein phosphatase 2A and thus sequestered and
inhibited the latter. The authors postulated that this
led to a net increase in the phosphorylation state of
signaling proteins that are responsible for RelA
activation. However, in their discussion, they stated
that although the recombinant P protein activatedRelA, the low levels of activation suggested that there
must be other viral gene products that play additional
or more important roles in an RSV-infected cell.
(ii) The M2-1 generated by recombinant expression and
RSV infection activated Rel A to a similar extent
(Fig. 2).
We demonstrated that M2-1 protein can be found in the
nuclei of RSV-infected cells as well as in cells transfected
with M2-1 encoding expression vector (Figs. 3 and 4). The
presence of M2-1 protein in nuclei of RSV-infected and M2-
1 cDNA-transfected cells was unexpected. Garcia et al.
(1993) demonstrated that in RSV-infected HEp-2 cells M2
protein is concentrated in cytoplasmic inclusions. Unfortu-
nately, in the immunoelectron microscopic studies, the
authors did not show nuclei of cells, which were stained
with a monoclonal antibody against M2 protein. In contrast
to A549 cells, the HEp-2 cells supported a robust multi-
plication of RSV without producing certain cytokines (Bitko
et al., 1997). So, induction of effector molecules may be
cell-specific and HEp-2 cells when compared to A549 cells
may be different in the signal transduction pathway that
leads from RSV to NF-nB. The kinetics of M2-1 trans-
location and the activation of NF-nB noted by us (data not
shown) are similar to those observed by other authors
(Garofalo et al., 1996; Jamaluddin et al., 1998). Although a
classical nuclear localization signal (NLS) was not revealed
by analysis of the deduced amino acid sequence of the M2-1
protein, the interaction of the M2-1 protein with Rel A in the
nuclei of both RSV-infected and M2-1cDNA-transfected
cells, as shown by co-immunoprecipitations (Fig. 5),
suggest that M2-1 may be transported into the nucleus by
binding to Rel A.
Direct interaction with the NF-nB complex has been
previously shown for some viral proteins, including the Tax
protein from human T-cell leukemia virus type 1 (HTLV-1)
and protein X of hepatitis B. Tax associates with different
members of the NF-nB/Rel family, the inhibitory precursor
proteins p100 and p105 (Beraud et al., 1994; Hirai et al.,
1992). Weil et al. (1999) demonstrated that protein X of the
hepatitis B virus interacts directly with resynthesized InBa,
which is then able to transport protein X into the nucleus.
According to their data, the interaction between protein X
and InBa and the resulting nuclear co-localization are at
least responsible for a sustained activation of NF-nB.
Although in this case, the viral protein X is exerting its
influence on the NF-nB complex through interaction with
the inhibitory subunit, we believe that the binding of M2-1
to Rel-A could be the cause of the persistence of NF-nB
activation after RSV infection.
In future experiments we will investigate whether M2-1
expression leads to degradation of InBa and/or InBh. In
previous studies it has been shown that short-term activation
of NF-nB, such as that caused by TNF-a, suggest the
degradation of InBa but not of InBh, whereas persistent
activators, like the viral proteins Tat from HIV-1 and Tax
K. Reimers et al. / Virology 331 (2005) 260–268266from HTLV-1, induce the degradation of both InBa and
InBg (Good and Sun, 1996; McKinsey et al., 1996).
Jamaluddin et al. (1998) and Bitko and Barik (1998)
demonstrated that RSV infection also resulted in the loss
of InBg.
The expression of C-terminal and N-terminal protein
fragments of M2-1 instead of the full-length protein made
clear that the NF-nB-activating domain is located at the C-
terminus of M2-1 (Figs. 6 and 7). Recent reports have stated
that the N-terminus of M2-1 carries an RNA-binding
domain located between amino acid residues 59 and 85
(Cuesta et al., 2000). The Cys3-His1 motif (C–X7–C–X5–
C–X3–H) near the amino terminus has been shown to be of
importance for the functional integrity of M2-1 as anti-
termination factor (Hardy and Wertz, 2000).
In conclusion, we have defined an additional role for the
M2-1 protein as an activator of NF-nB. Identifying a single
viral gene product as an NF-nB activator may have
important implications in RSV immunopathology.Materials and methods
RSV strain and purification
The human Long strain of RSV was grown in Hep-2
cells and purified by centrifugation in discontinuous sucrose
gradients, as described (Ueba, 1980). The virus titer of the
purified RSV pools was 7.5–8.5 log PFU/ml. Virus pools
were quick frozen on dry ice/alcohol and stored at 70 8C
until used.
Cell culture and infection of epithelial cells with RSV
A549, human alveolar type II-like epithelial cells
(American Type Culture Collection, Manassas, VA), were
maintained in DMEM medium containing 10% (v/v) FBS,
10 mM glutamine, 100 IU/ml penicillin, and 100 Ag/ml
streptomycin. Cell monolayers were infected with RSV at
multiplicity of infection (MOI) of 1, as described (Garofalo,
1996). An equivalent amount of a 20% sucrose solution was
added to uninfected A549 cells, as control.
cDNA constructs and transfection of A549 cells
cDNAs encoding full-length RSV (strain Long) were
cloned by RT-PCR using Superscript RT-PCR systems
(Invitrogen, Carlsbad, CA) according to manufacturer’s
instructions. Specific primers were generated after published
RSV sequences (strain A2). The complete coding sequences
were cloned into the expression vector pTriEx (Novagen,
Madison, WI). Cells were transfected using the non-
liposomal transfection reagent Fugene6 (Roche Molecular
Biochemicals, Mannheim, Germany) according to manu-
facturer’s instructions. Briefly, cells were seeded in 6-well
plates and grown overnight to subconfluency. Transfectionreagent was mixed with serum-free culture medium and
incubated for 10 min at room temperature. Plasmid DNA
was added at 3.75 Ag/well and incubated for 15 min at room
temperature. Cells were incubated for 2 h with the
transfection mixture and then fed. Cells were used after
24–48 h.
Isolation of nuclear extracts
A549 nuclear extracts were essentially prepared as
described (Schreiber et al., 1989). Briefly, exponentially
growing cells were washed twice with ice-cold 1
phosphate-buffered saline and then recovered in 1 ml of
phosphate-buffered saline. After centrifugation for 30 s in a
microcentrifuge, the cells were resuspended in 1.2 ml of
lysis buffer A (10 mM KCl, 10 mM HEPES, pH 7.9, 0.1
mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.2 mM
phenylmethylsulfonyl fluoride, and allowed to swell on ice
for 20 min. Then, 37.5 Al of 10% Nonidet P-40 were added
to the cell suspension, and the mixture was mixed
vigorously for 10–15 s and centrifuged for 1 min in a
microcentrifuge. The nuclear pellets were resuspended in
20–30 Al of ice-cold extraction buffer B (0.4 M NaCl, 20
mM HEPES, pH 7.9, 1 mM EDTA, 1 mM EGTA), and the
nuclear proteins were extracted by constant mixing at 4 8C
for 30 min. Cell debris was removed by centrifugation, and
the nuclear extracts were either used immediately or stored
in small aliquots at 70 8C. The protein concentrations of
the nuclear extracts were determined by the Bradford
method (1976).
Electrophoretic mobility shift assay (EMSA)
A double-stranded oligonucleotide containing a consen-
sus sequence for the NFnB binding site was used:
5V-AGTTGAGGGGACTTTCCCAGGC-3V, 3V-TCAACT-
CCCCTGAAAGGGTCCG-5V. Five nanograms of double-
stranded oligonucleotide were end-labeled in polynucleo-
tide kinase buffer (60 mM Tris–HCl, pH 7.5, 10 mM
MgCl2, 15 mM h-mercaptoethanol, 0.33 AM ATP) using
T4 polynucleotide kinase in the presence of 100 ACi of
[g-32P]ATP (ICN). Five micrograms of nuclear extract
were mixed with incubation buffer (10 mM Tris–HCl, pH
7.5, 100 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 4%
(v/v) glycerol, 0.08 mg/ml sonicated salmon sperm DNA)
and incubated at 4 8C for 15 min. The labeled oligonucleo-
tides (40,000–100,000 dpm) were added to the preincu-
bated mixture and the incubation continued at room
temperature for 20 min. For competition assays, a 20-fold
access of cold-labeled oligonucleotides was added. Reac-
tion mixtures were run on a 4% non-denaturing polyacry-
lamide gel at 100 V until the front dye reached 2–3 cm
from the bottom of the gel. Following completion, the gel
was transferred to blotter paper and dried under vacuum.
The dried gel was placed in the PhosphorImager screen and
exposed overnight.
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An ELISA-based assay for NFnB activation was
performed following the recommendations of the manufac-
turer (Active Motif, Carlsbad, CA). Briefly, 20 Al nuclear
extract containing 5 Ag total protein were placed into a 96-
well plate coated with immobilized oligonucleotide con-
taining the NFnB consensus site (5V-GGGACTTTCC-3V) and
incubated for 1 h at room temperature. Following this, the
wells were washed three times with the included washing
buffer. Subsequently, NFnB p65 antibody was added at the
recommended concentration and incubated for 1 h at room
temperature. After washing three times, HRP-conjugated
secondary antibody was added and incubated for 1 h at
room temperature. The amount of NFnB p65 was deter-
mined colorimetrically 10 min later after adding stopping
solution (450 nm wavelength, Genios microplate reader,
Tecan, Austria).
Luciferase assay
The pNFB-LUC plasmid containing five copies of
consensus NFB site linked to a minimal E1B promoter-
luciferase reporter gene was purchased from Stratagene (La
Jolla, CA). In a typical experiment, a 35-mm diameter dish
containing 106 A549 cells, 0.625 Ag of pNFB-LUC was
cotransfected with 0.625 Ag expression plasmid. Forty-eight
hours after transfection, luciferase activity was measured
with standard luciferase assays. Freshly reconstituted
luciferase assay buffer (100 Al) was added to 20 Al cellular
lysate in reporter lysis buffer (Promega, Madison, WI) and
luciferase activity was quantified as relative light units
using a standard luminometer. Luciferase activity was
normalized for protein concentration using the Bradford
assay.
Indirect immunofluorescence
Cells were fixed with 4% (w/v) paraformaldehyde for 20
min at room temperature, rinsed, and permeabilized in
phosphate-buffered saline (PBS) containing 0.2% (w/v)
Triton-X-100 for 4 min, 24 h after transfection. Blocking
was performed with 2% FBS in PBS. Incubation with the
primary antibodies was done at a 1/400 dilution in PBS/1%
FBS overnight at 4 8C or, alternatively, for 1 h at 37 8C. The
secondary antibody was Alexa Fluor 488 goat anti-rabbit
IgG (approximate absorption 495 nm and fluorescent
emission 519 nm, green fluorescent) or Alexa Fluor 594
goat anti-mouse IgG (approximate absorption 590 nm and
fluorescent emission 617 nm, red fluorescent) (Molecular
Probes, Leiden, The Netherlands), respectively, at a 1/800
dilution in PBS/1% FBS. After being washed in PBS, cells
were mounted with Vectashield/DAPI (Vector Laboratories,
CA), and cells were examined with a 64 oil immersion
lens on a Zeiss microscope with the appropriate barrier
filters.Co-immunoprecipitation
Dynabeads Protein G (Dynal Biotech Inc., Brown Deer,
WI) were washed according to manufacturer’s instructions
and finally resuspended in 0.5 ml 0.1M Na-citrate pH 5.
Samples were added and incubated for up to 40 min at room
temperature. Test tubes were placed in a magnet reck and
the supernatant was removed. After three washing steps
with 0.5 ml 0.1 M Na-citrat pH 5 protein complexes were
eluted two times with 30 Al 0.1 M Na-citrate buffer pH 2.
Samples were subjected to SDS-PAGE followed by Western
blotting.
For nuclease treatment the samples were mixed with
either RNAseA or DNAseI at a final concentration of 1.6
Ag/Al. Samples were incubated at 37 8C for 15 min.
Dynobeads were added and continued as described.
Statistics
Data were collected from at least three independent
experiments and presented as the mean and SEM. The
significance of differences was determined by Student’s t
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